Stock Price
8.84
Daily Change
0.20 2.31%
Monthly
-11.69%
Yearly
47.09%
Q2 Forecast
8.65

Novavax reported $11.54M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Adma Biologics USD 206.46M 9.8M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
BioCryst Pharmaceuticals USD 5.4M 166K Dec/2025
Geron USD 116.64M 21.21M Dec/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
MannKind USD 35.31M 8.34M Dec/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Novavax USD 11.54M 1.97M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
TG Therapeutics USD 125.59M 21.37M Dec/2025